跳到正文
原文
Nature 健康护理主题·· 16 天前AI 评分46

30个欧洲国家通过搜索引擎接触合法和非法在线药店

Exposure to legitimate and illegal online medicine vendors via search engines in 30 European countries

AI 导读

研究发现,30个欧洲国家的搜索引擎结果中,63.7%的链接指向合法在线药店,36.3%指向非法在线药店。尽管合法在线药店占主导,但消费者仍面临较高风险,特别是在销售受控物质和禁止在线销售的国家。

正文

npj Digital Medicine (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Online medicine sales have not only improved access but also expose consumers to illegal online medicine vendors (IOMVs) selling substandard/falsified products. This study provides the first pan-European assessment of exposure to legitimate online pharmacies (LOPs) and IOMVs in search engine results (SERs). We scraped the top-50 Google results in 30 European countries for six tracer active pharmaceutical ingredients across three categories: controlled substances, prescription-only medicines (POMs), and over-the-counter products (OTCs). Links were categorised as LOPs or IOMVs based on official registries. From 9000 SERs, 3839 linked to medicine-selling websites (63.7% LOPs, 36.3% IOMVs). LOPs outnumbered and outranked IOMVs, though IOMV:LOP ratios reached 2.37 (Norway) and 2.18 (Cyprus). Search engine redirection affected 56.6% of IOMV links. IOMV prevalence increased with regulatory control: 1.4% (paracetamol), 5.5% (ibuprofen), 10.2% (omeprazole), 55.1% (amoxicillin), 76.2% (alprazolam) and 77.5% (clonazepam). IOMV links were less likely to be highest-ranked and less common in the top-10 SERs in countries permitting online OTC and POM sales, than in those prohibiting them. Despite LOP dominance, Europeans face substantial exposure to IOMV links, higher for controlled substances and in countries prohibiting online sales. Harmonised regulatory action, supported by search engine providers, is needed for safer online medication access.

Acknowledgements

The research was supported by the Hungarian Scientific Research Fund OTKA grant NKFI-ID:143684. Catherine Goodman and Benjamin Palafox were supported by a Health Systems Research Initiative grant (Ref: MR/V02096X/1) jointly funded by the UK Foreign, Commonwealth & Development Office (FCDO), the UK Medical Research Council (MRC) and The Wellcome Trust. The funders had no role in the study design; the collection, analysis and interpretation of data; the writing of the manuscript; or the decision to submit for publication.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy, University of Pécs, Pécs, Hungary

    András Fittler, Amir Reza Ashraf, Bálint Márk Domián, Luca Sebők & Róbert György Vida

  2. Department for Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK

    Benjamin Palafox & Catherine Goodman

  3. The School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, The University of Dublin, Dublin, Ireland

    Bernard D. Naughton

  4. Centre for Pharmaceutical Medicine Research, Kings College London, London, UK

    Bernard D. Naughton

Authors

  1. András Fittler
  2. Amir Reza Ashraf
  3. Benjamin Palafox
  4. Bálint Márk Domián
  5. Bernard D. Naughton
  6. Luca Sebők
  7. Róbert György Vida
  8. Catherine Goodman

Corresponding author

Correspondence to András Fittler.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fittler, A., Ashraf, A.R., Palafox, B. et al. Exposure to legitimate and illegal online medicine vendors via search engines in 30 European countries. npj Digit. Med. (2026). https://doi.org/10.1038/s41746-026-03432-5

Download citation

  • Received: 08 July 2025

  • Accepted: 09 October 2026

  • Published: 05 November 2026

  • DOI: https://doi.org/10.1038/s41746-026-03432-5

来源:Nature 健康护理主题 · nature.com